Back
About
ASP Isotopes Inc. is engaged in the development of innovative materials and improving isotope enrichment technology. The company's end products are mainly aimed at medical applications, such as the production of raw materials for radiopharmaceuticals.
ASP Isotopes has a patented aerodynamic separation technology (ASP) developed by specialists from Klydon on their order. All rights to commercialize ASP belong to ASP Isotopes. Klydon also transferred the first installation for industrial production of the molybdenum-100 isotope.
This is a weakly radioactive isotope that is used, for example, in the study of double beta decay, which is closely related to neutrino physics. But above all, ASP Isotopes expects to sell molybdenum-100 as a raw material for the production of the technetium-99m isotope, which is widely used in medical diagnostics.
The value of the ASP Isotopes commercial idea is that the company is the first to offer an alternative production of technetium-99m. Until now, this isotope has been produced with great difficulty from the short-lived molybdenum-99 isotope, which needs to be extracted from the reactor's active zone, resulting in the isotope costing tens of millions of dollars per gram.
An additional direction of ASP Isotopes is the adaptation of the ASP technology for the enrichment of uranium-235, which can be used as an additive to fuel in small modular reactors of the new generation.
__________________________
Number of employees
2-10
__________________________
Location of the headquarters
Boca Raton, Florida, USA
Calls within Tajikistan are free
Investments
Information
The information provided is for informational purposes only and should not be considered as an offer to buy or sell foreign currency, securities and/or other financial instruments. The information presented on this website is not an individual investment recommendation. Financial instruments or transactions mentioned in this section may not be suitable for you, may not correspond to your investment profile, financial situation, investment experience, knowledge, investment objectives, attitude to risk and profitability.
LLC "Exchange Broker" does not guarantee and does not promise future profitability of investments, does not guarantee the reliability of possible investments and the stability of possible income. Investment results in the past do not guarantee income in the future.
LLC "Exchange Broker" is not responsible for possible investor losses in the event of transactions and investments in financial instruments, and also does not guarantee the return, effectiveness and profitability of investments.
LLC "Exchange Broker" hereby informs that it operates in the securities market in accordance with the following professional participant licenses issued by the Ministry of Finance of the Republic of Tajikistan: depository activity No.010/25 dated 25.06.2025; brokerage activity No.007/25 dated 25.06.2025; dealer activity No.008/25 dated 25.06.2025 and securities management activity No.009/25 dated 25.06.2025, and also informs about the risk of a conflict of interest, including as a result of combining various types of professional activity in the securities market.